Qinlong Zheng - 2Nordic Bioscience Beijing

基本信息

浏览量：56

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 112 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Identifying Risk Factors for Severe Omicron Infection in Allogeneic Hematopoietic Stem Cell Transplant Recipients with Hematologic Malignancies

Zhihui Li, Lei Wang,Qinlong Zheng,Teng Xu,Keyan Yang,Xianxuan Wang,Xiaopei Wen,Caiyan Zhang,Jingjing Wang,Yanzhi Song,Yongqiang Zhao, Xiaoyu Zheng,Tong Wu

Cancer Reportsno. 6 (2024)

引用0浏览0WOS引用

Five-year Outcome of CD19 Combined with CD22 CAR-T Cell Therapy in Patients with B-ALL Relapsed after Allo-transplantation

Shuangyou Liu,Lihong An,Zhichao Yin,Yuehui Lin, Zhuojun Lin,Biping Deng,Xinjian Yu,Qinlong Zheng,Defeng Zhao,Tong Wu,Alex Chang,Chunrong Tong

EMJ Hematologypp.46-48, (2024)

引用0浏览0引用

Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Improved Prognosis for Advanced NK/T Cell Lymphoma

Zhihui Li,Xianxuan Wang,Keyan Yang, Lei Wang,Xiaopei Wen,Jingjing Wang, Jing Li,Yanzhi Song,Yongqiang Zhao,Qinlong Zheng,Tong Wu

Bloodno. Supplement 1 (2024): 599-599

引用0浏览0引用

CD7 CART Therapy Bridging Allo-HSCT Remarkably Improves Long-Term DFS in Refractory/Relapsed T-ALL/LBL

Zhihui Li,Qinlong Zheng,Keyan Yang,Teng Xu, Lei Wang,Xianxuan Wang, Wiaopei Wen,Jingjing Wang,Yongqiang Zhao,Yanzhi Song, Chen, Qi Zhou,Tong Wu

Transplantation and Cellular Therapy (2024)

引用0浏览0WOS引用

Allogeneic CD5-specific CAR-T Therapy for Relapsed/refractory T-ALL: a Phase 1 Trial

Jing Pan,Yue Tan,Lingling Shan,Samuel Seery,Biping Deng,Zhuojun Ling,Jinlong Xu,Jiajia Duan,Zelin Wang, Kai Wang,Xinjian Yu,Qinlong Zheng,Xiuwen Xu,Guang Hu,Taochao Tan,Ying Yuan,Zhenglong Tian,Fangrong Yan, Yajing Han,Jiecheng Zhang,Xiaoming Feng

Nature Medicineno. 1 (2024): 126-136

引用0浏览0WOSNATURE引用

Five-year Outcomes of CD19 Followed by CD22 Chimeric Antigen Receptor T-cell Therapy in B-cell Acute Lymphoblastic Leukemia Patients Who Relapsed after Allo-Transplantation

Shuangyou Liu,Lihong An,Zhichao Yin,Yuehui Lin,Zhuojun Ling,Biping Deng,Xinjian Yu,Qinlong Zheng,Defeng Zhao,Tong Wu,Alex H Chang,Chunrong Tong

Haematologicano. 5 (2024): 1192-1196

引用0浏览0WOS引用

Impact of CD58 Mutations on CAR-T Cell Therapy in B-Cell Non-Hodgkin Lymphoma: Clinical Insights and Therapeutic Potential

Bian Wei,Rui Liu,Fan Yang,Lixia Ma,Yuelu Guo,Qinlong Zheng,Biping Deng, Zhonghua Fu,Xiaoyan Ke,Kai Hu

Bloodno. Supplement 1 (2024): 6549-6549

引用0浏览0引用

Transcriptome Data Analysis of 80 B ALL Patients in China

Yuehui Lin, Dan Liu, Yu Xia,Tong Wu,Qinlong Zheng

Bloodno. Supplement 1 (2024): 5924-5924

引用0浏览0引用

Activity of Trametinib As Maintenance Therapy after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory RAS Pathway-Mutated Hematologic Malignancies

Zhihui Li,Keyan Yang,Teng Xu, Lei Wang,Xianxuan Wang,Xiaopei Wen,Caiyan Zhang,Jingjing Wang, Xiaoyu Zheng,Tong Wu,Qinlong Zheng

Annals of Hematologypp.1-7, (2024)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn